Salarius Pharmaceuticals, Inc. (SLRX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Total Current Assets | 6.06M | 1.36M | 2.31M | 2.99M | 3.82M | 3.51M | 4.83M | 6.52M | 8.32M | 11.96M | 9.94M | 14.52M | 17.97M | 23.02M | 24.86M | 30.16M | 35.18M | 38.31M | 41.65M | 15.8M |
| Cash & Short-Term Investments | 4.81M | 794.89K | 1.8M | 2.43M | 3.28M | 3.27M | 4.37M | 5.9M | 7.58M | 11.54M | 9.27M | 12.11M | 16.82M | 22.65M | 24.19M | 29.21M | 31.9M | 33.08M | 36.61M | 11.12M |
| Cash Only | 4.81M | 794.89K | 1.8M | 2.43M | 3.28M | 3.27M | 4.37M | 5.9M | 7.58M | 11.54M | 9.27M | 12.11M | 16.82M | 22.65M | 24.19M | 29.21M | 31.9M | 33.08M | 36.61M | 11.12M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130K | 130K | 1.61M | 0 | 0 | 0 | 0 | 2.09M | 4.79M | 4.22M | 3.86M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.06K | 1.21K | 951.67 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -525.44K | 0 | 0 | 0 | 0 | 0 | 0 | -117.31K | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.26M | 564.69K | 286.24K | 221.58K | 0 | 0 | 178.07K | 151.27K | 0 | 284.81K | 525.44K | 0 | 0 | 215.64K | 0 | 172.99K | 95.23K | 258.86K | 206.49K | 0 |
| Total Non-Current Assets | 32.09K | 33.2K | 34.31K | 35.41K | 36.52K | 39.93K | 53.39K | 66.85K | 80.44K | 99.05K | 114.85K | 130.5K | 1.76M | 10.64M | 10.65M | 10.67M | 9.08M | 9.1M | 9.12M | 9.14M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.19K | 7.88K | 11.57K | 15.26K | 18.95K | 22.64K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -233.53x | - | 37.44x | 66.96x | 65.33x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.87M | 8.87M | 8.87M | 8.87M | 8.87M | 8.87M | 8.87M | 8.87M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.61M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 32.09K | 33.2K | 34.31K | 35.41K | 36.52K | 39.93K | 53.39K | 66.85K | 80.44K | 99.05K | 114.85K | 130.5K | -7.11M | 162.42K | 1.78M | 1.8M | 201.39K | 216.79K | 232.03K | 247.11K |
| Total Assets | 6.1M | 1.39M | 2.34M | 3.02M | 3.86M | 3.55M | 4.88M | 6.59M | 8.4M | 12.06M | 10.06M | 14.65M | 19.72M | 33.65M | 35.51M | 40.83M | 44.26M | 47.4M | 50.77M | 24.93M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.05x | - | 0.01x | 0.02x | 0.06x |
| Asset Growth % | 57.99% | -60.81% | -52.1% | -54.1% | -54.08% | -70.52% | -51.43% | -55.04% | -57.39% | -64.18% | -71.68% | -64.12% | -55.44% | -29.01% | -30.06% | 63.78% | 91.92% | 155.39% | 153.01% | 79.44% |
| Total Current Liabilities | 1.1M | 1.48M | 2.28M | 1.51M | 934.58K | 1.18M | 1.23M | 1.3M | 2.32M | 3.64M | 4.5M | 4.27M | 3.11M | 2.77M | 2.09M | 2.11M | 1.61M | 1.55M | 1.99M | 2.77M |
| Accounts Payable | 1.1M | 1.48M | 1.47M | 936.99K | 165.8K | 643.05K | 713.96K | 602.85K | 1.09M | 2.29M | 3.51M | 2.86M | 1.72M | 1.87M | 1.69M | 1.54M | 1.23M | 1.28M | 1.57M | 1.85M |
| Days Payables Outstanding | 364.4K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 112.23K | 221.87K | 328.85K | 0 | 116.86K | 289.64K | 459.09K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 191.4K | 477.03K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | -740.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 895.11K | 8.71K | 0 | 54.01K | 63.08K | 105.27K | 59.21K |
| Current Ratio | 5.49x | 0.92x | 1.01x | 1.98x | 4.09x | 2.98x | 3.91x | 5.02x | 3.59x | 3.28x | 2.21x | 3.40x | 5.78x | 8.31x | 11.88x | 14.29x | 21.82x | 24.66x | 20.94x | 5.70x |
| Quick Ratio | 5.49x | 0.92x | 1.01x | 1.98x | 4.09x | 2.98x | 3.91x | 5.02x | 3.59x | 3.28x | 2.33x | 3.40x | 5.78x | 8.31x | 11.88x | 14.29x | 21.82x | 24.73x | 20.94x | 5.70x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 744.78K | 740.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 744.78K | 740.55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.85M | 2.22M | 2.28M | 1.51M | 934.58K | 1.18M | 1.23M | 1.3M | 2.32M | 3.64M | 4.5M | 4.27M | 3.11M | 2.77M | 2.09M | 2.11M | 1.61M | 1.55M | 1.99M | 2.77M |
| Total Debt | 0 | 0 | 112.23K | 221.87K | 328.85K | 0 | 116.86K | 289.64K | 459.09K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 191.4K | 477.03K |
| Net Debt | -4.81M | -794.89K | -1.69M | -2.21M | -2.96M | -3.27M | -4.26M | -5.61M | -7.12M | -11.54M | -9.27M | -12.11M | -16.82M | -22.65M | -24.19M | -29.21M | -31.9M | -33.08M | -36.42M | -10.64M |
| Debt / Equity | - | - | 1.81x | 0.15x | 0.11x | - | 0.03x | 0.05x | 0.08x | - | - | - | - | - | - | - | - | - | 0.00x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1447.15x | -629.35x |
| Total Equity | 4.25M | -829.72K | 61.87K | 1.51M | 2.92M | 2.38M | 3.65M | 5.29M | 6.08M | 8.41M | 5.56M | 10.38M | 16.61M | 30.88M | 33.42M | 38.72M | 42.65M | 45.85M | 48.78M | 22.16M |
| Equity Growth % | 45.25% | -134.93% | -98.3% | -71.41% | -51.93% | -71.77% | -34.35% | -49.09% | -63.38% | -72.76% | -83.36% | -73.18% | -61.05% | -32.64% | -31.49% | 74.75% | 106.98% | 172.03% | 170.95% | 109.43% |
| Book Value per Share | 8.82 | -5.83 | 0.55 | 23.45 | 34.05 | 59.05 | 103.89 | 160.30 | 193.50 | 370.84 | 277.49 | 550.23 | 882.48 | 1722.48 | 2156.47 | 2555.72 | 2841.57 | 3058.10 | 4765.94 | 3182.49 |
| Total Shareholders' Equity | 4.25M | -829.72K | 61.87K | 1.51M | 2.92M | 2.38M | 3.65M | 5.29M | 6.08M | 8.41M | 5.56M | 10.38M | 16.61M | 30.88M | 33.42M | 38.72M | 42.65M | 45.85M | 48.78M | 22.16M |
| Common Stock | 94 | 213 | 208 | 144 | 144 | 64 | 431 | 393 | 394 | 335 | 246 | 225 | 224 | 5.61K | 4.67K | 4.52K | 4.52K | 4.48K | 4.47K | 2.38K |
| Retained Earnings | -85.46M | -84.59M | -83.63M | -81.92M | -80.46M | -79.49M | -78.06M | -76.35M | -75.47M | -73.02M | -69.15M | -63.81M | -57.43M | -43.02M | -38.31M | -32.2M | -28.09M | -24.36M | -21.28M | -19.43M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |